Role of Hexokinase and VDAC in Neurological Disorders

E-ISSN： 1874-4702|9|4|320-331

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.9, Iss.4, 2016-11, pp. : 320-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Cytokines in Neurological Disorders

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1931-1937

Bentham Science Publishers

Access to resources Recommend Favorite

Role of HMG-CoA Reductase Inhibitors in Neurological Disorders: Progress to Date

By Reiss Allison B.

Drugs, Vol. 67, Iss. 15, 2007-01 ,pp. : 2111-2120

Adis International

Access to resources Recommend Favorite

Structure-Function of Prolyl Oligopeptidase and its Role in Neurological Disorders

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 4, 2002-12 ,pp. : 251-257

Bentham Science Publishers

Access to resources Recommend Favorite

Role of CNS Transporters in the Pharmacotherapy of HIV-1 Associated Neurological Disorders

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1543-1563

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy

By Krasnov George S Dmitriev Alexey A Lakunina Valentina A Kirpiy Alexander A Kudryavtseva Anna V

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1221-1233

Informa Healthcare

Access to resources Recommend Favorite